
One year ago President Donald Trump promised to “love and cherish” Medicaid. Alas, his affection for the public insurance program was short-lived. The

A Democrat running for Senate in Texas has a complicated history with corporate America and the crypto industry.

Friedrich Merz has his own strategy for dealing with the U. S. president, but the verdict is not yet in.

Ad makers will never say the quiet part loud, but they increasingly know that we're unhappy and looking for solutions.

Spencer Kuvin, an attorney representing nine of Epstein’s victims, discusses the failures of the DOJ to protect survivors.

Even trace amounts of the toxic metal can cause learning problems and behavioral issues in children.

New SEC restrictions could sideline the small shareholders who have driven high-profile climate fights in recent years.

With locals distributing food aid to immigrants to prevent hunber, fear and uncertainty remain as Trump’s historic occupation dies down.

Waxes containing PFAS are banned at the Milan-Cortina Games. Three athletes already have been disqualified for using them.

But European officials remain divided on how best to address U. S. unpredictability and Chinese competition.

After the DOJ dodged questions for months, Bondi acknowledged in a hearing that she had a list of targets under NPSM-7.

The EPA’s repeal of the “endangerment finding” could threaten automakers and oil companies — if it survives in court.

This film makes cold calling names from the phone book look as thrilling as Indiana Jones outsmarting the Nazis.

The visit suggests a possible FBI probe into Extinction Rebellion NYC as the Trump administration increases surveillance of activist groups.